Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Parkinson-linked genes and toxins that affect neuronal cell death through the Bcl-2 family.

Ethell DW, Fei Q.

Antioxid Redox Signal. 2009 Mar;11(3):529-40. doi: 10.1089/ARS.2008.2228. Review.

PMID:
18715146
2.

Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.

Sun F, Kanthasamy A, Anantharam V, Kanthasamy AG.

Pharmacol Ther. 2007 Jun;114(3):327-44. Epub 2007 Apr 19. Review.

PMID:
17521740
3.

Heredity in Parkinson's disease: new findings.

Lev N, Melamed E.

Isr Med Assoc J. 2001 Jun;3(6):435-8. Review.

4.

Maneb potentiates paraquat neurotoxicity by inducing key Bcl-2 family members.

Fei Q, Ethell DW.

J Neurochem. 2008 Jun 1;105(6):2091-7. doi: 10.1111/j.1471-4159.2008.05293.x.

5.

Parkinson disease: from pathology to molecular disease mechanisms.

Dexter DT, Jenner P.

Free Radic Biol Med. 2013 Sep;62:132-44. doi: 10.1016/j.freeradbiomed.2013.01.018. Epub 2013 Feb 4.

PMID:
23380027
6.

Cell death pathways in Parkinson's disease: role of mitochondria.

Yao Z, Wood NW.

Antioxid Redox Signal. 2009 Sep;11(9):2135-49. doi: 10.1089/ARS.2009.2624. Review.

PMID:
19422283
7.

Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.

Perfeito R, Cunha-Oliveira T, Rego AC.

Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3. Review.

PMID:
23743292
8.

Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K.

Choong CJ, Say YH.

Neurotoxicology. 2011 Dec;32(6):857-63. doi: 10.1016/j.neuro.2011.05.012. Epub 2011 May 30.

PMID:
21658409
9.

Programmed cell death in Parkinson's disease.

Venderova K, Park DS.

Cold Spring Harb Perspect Med. 2012 Aug 1;2(8). pii: a009365. doi: 10.1101/cshperspect.a009365. Review.

10.

Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?

Hartmann A, Michel PP, Troadec JD, Mouatt-Prigent A, Faucheux BA, Ruberg M, Agid Y, Hirsch EC.

J Neurochem. 2001 Mar;76(6):1785-93.

11.
12.

Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.

Triplett JC, Zhang Z, Sultana R, Cai J, Klein JB, Büeler H, Butterfield DA.

J Neurochem. 2015 Jun;133(5):750-65. doi: 10.1111/jnc.13039. Epub 2015 Mar 1.

13.

Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis.

Tanaka Y, Engelender S, Igarashi S, Rao RK, Wanner T, Tanzi RE, Sawa A, L Dawson V, Dawson TM, Ross CA.

Hum Mol Genet. 2001 Apr 15;10(9):919-26.

PMID:
11309365
14.

Etiology of Parkinson's disease.

Schapira AH.

Neurology. 2006 May 23;66(10 Suppl 4):S10-23.

PMID:
16717248
15.

Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson's model.

Ray A, Martinez BA, Berkowitz LA, Caldwell GA, Caldwell KA.

Cell Death Dis. 2014 Jan 9;5:e984. doi: 10.1038/cddis.2013.513.

16.

An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage.

Sherer TB, Betarbet R, Stout AK, Lund S, Baptista M, Panov AV, Cookson MR, Greenamyre JT.

J Neurosci. 2002 Aug 15;22(16):7006-15.

17.

Mechanistic approaches to Parkinson's disease pathogenesis.

Betarbet R, Sherer TB, Di Monte DA, Greenamyre JT.

Brain Pathol. 2002 Oct;12(4):499-510. Review.

PMID:
12408237
18.

Mitochondria in the aetiology and pathogenesis of Parkinson's disease.

Schapira AH.

Lancet Neurol. 2008 Jan;7(1):97-109. Review.

PMID:
18093566
19.

Nigrostriatal neuronal death in Parkinson's disease--a passive or an active genetically-controlled process?

Ziv I, Barzilai A, Offen D, Nardi N, Melamed E.

J Neural Transm Suppl. 1997;49:69-76. Review.

PMID:
9266415
20.

Pathogenesis of Parkinson's disease.

Sherer TB, Betarbet R, Greenamyre JT.

Curr Opin Investig Drugs. 2001 May;2(5):657-62. Review.

PMID:
11569943

Supplemental Content

Support Center